Trial Profile
Pharmacokinetic Interaction Between Coartem and Either Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Artemether/lumefantrine (Primary) ; Efavirenz (Primary) ; Nevirapine (Primary) ; Rifampicin (Primary)
- Indications HIV infections; Tuberculosis
- Focus Pharmacokinetics
- 27 Jul 2012 Results presented at the 19th International AIDS Conference.
- 14 Dec 2010 New trial record